Epigral

MFL30 Apr 2024

Chemicals

₹

+9.60 (+0.73%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Epigral

Epigral

Chemicals

MFL30 Apr 2024

₹

+9.60 (+0.73%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
25-Apr-2023	D	Meghmani Finechem Limited informs that the Board of Directors at its meeting held today i.e. Tuesday, 25th April, 2023 has inter-alia transacted the following business: Recommended final dividend of Rs. 2.50 (25%) per equity share on 4,15,50,158 Equity Shares of Rs. 10/- each for the financial year ended 31st March, 2023, subject to approval of the Shareholders of the Company at the forthcoming Annual General Meeting. Meghmani Finechem Limited submits the Intimation of Record Date for Dividend. (As Per BSE Announcement Dated on 03/06/2023)	20-Jun-2023
19-Jan-2023	D	The Board of Directors of the Company at its meeting held today i.e. on 19th January, 2023 has also declared Interim Dividend at Rs. 2.50/- (i.e. 25%) per Equity Share on 4,15,50,158 Equity Shares of Rs. 10/- each for the year FY 2022-23. Meghmani Finechem Limited informs that the Board of Directors of the Company at its meeting held today i.e. on 19th January, 2023 has also declared Interim Dividend at Rs. 2.50/- (i.e. 25%) per Equity Share on 4,15,50,158 Equity Shares of Rs. 10/- each for the year FY 2022-23.	01-Feb-2023
22-Apr-2024	BC	Appointment of Mr. Gaurang Trivedi (ACS 22307) as Company Secretary andCompliance Officer (Key Managerial Personnel - KMP) of the Company w.e.f. 23rd April, 2024. Appointment of Mr. Gaurang G. Tr	23-Apr-2024
09-Apr-2024	BC	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/04/2024 inter alia to consider and approve Audited Financial Results for the quarter and year	22-Apr-2024
22-Apr-2024	BC	Audited Financial Results for the quarter and year ended on 31.03.2024. Superannuation of Mr. Kamlesh Dinkerray Mehta (FCS 2051) as Company Secretary and Compliance Officer of the Company w.e.f.	22-Apr-2024
22-Apr-2024	BC	Outcome of Board Meeting held on Monday, 22nd April, 2024 Recommended final dividend of Rs. 5.00(50.00%) per equity share on 4,15,50,158 Equity Shares of Rs. 10/- each for the financial year ende	31-Mar-2024
02-Jan-2024	BC	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve Un-Audited Financial Results of the Company for the	24-Jan-2024

No Rights has been declared by MFL

Book Closure

Record Date	Split Date	Purpose
23-Apr-2024	-	Appointment of Mr. Gaurang Trivedi (ACS 22307) as Company Secretary andCompliance Officer (Key Managerial Personnel - KMP) of the Company w.e.f. 23rd April, 2024. Appointment of Mr. Gaurang G. Tr
22-Apr-2024	-	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/04/2024 inter alia to consider and approve Audited Financial Results for the quarter and year
22-Apr-2024	-	Audited Financial Results for the quarter and year ended on 31.03.2024. Superannuation of Mr. Kamlesh Dinkerray Mehta (FCS 2051) as Company Secretary and Compliance Officer of the Company w.e.f.
31-Mar-2024	-	Outcome of Board Meeting held on Monday, 22nd April, 2024 Recommended final dividend of Rs. 5.00(50.00%) per equity share on 4,15,50,158 Equity Shares of Rs. 10/- each for the financial year ende
24-Jan-2024	-	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve Un-Audited Financial Results of the Company for the

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Epigral Ltd ₹1,323.25(+9.60/0.73%)	1,323.25	+9.60	5,498.12	40.47	28.08	4.38
BASF India Ltd ₹3,735.05(-7.45/-0.20%)	3,735.05	-7.45	16,169.03	55.85	34.18	5.52
Bhagawati Oxygen Ltd ₹50.49(+0.74/1.49%)	50.49	+0.74	11.66	21.66	7.99	1.72
Atul Ltd ₹5,985.30(+25.15/0.42%)	5,985.30	+25.15	17,621.77	-9.15	45.82	3.46
Oriental Aromatics Ltd ₹367.20(-12.90/-3.39%)	367.20	-12.90	1,235.76	-10.84	0.00	1.99
Advance Petrochemicals Ltd ₹204.65(-3.35/-1.61%)	204.65	-3.35	18.42	-53.37	0.00	5.30

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Gross Sales	524.63	471.52	478.15	454.89	562.18	537.84
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	524.63	471.52	478.15	454.89	562.18	537.84
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.52	2.46	1.00	1.52	4.54	-0.26
Total Income	526.16	473.98	479.15	456.42	566.72	537.58
Total Expenditure	369.24	348.75	370.29	359.70	407.46	371.32
PBIDT	156.91	125.23	108.86	96.72	159.25	166.27
Interest	13.69	20.19	21.27	18.33	18.99	21.03
PBDT	143.23	105.04	87.59	78.38	140.26	145.23
Depreciation	30.38	30.88	31.51	30.80	30.13	30.84
Tax	19.94	13.58	10.34	8.85	20.08	20.69
Deferred Tax	16.24	11.27	7.61	7.05	13.25	16.51
Reported Profit After Tax	76.67	49.31	38.13	31.68	76.80	77.20
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	76.67	49.31	38.13	31.68	76.80	77.20

EPS (Unit Curr.)	18.45	11.87	9.18	7.62	18.48	18.58
EPS (Adj) (Unit Curr.)	18.45	11.87	9.18	7.62	18.48	18.58
Calculated EPS (Unit Curr.)	18.45	11.87	9.18	7.62	18.48	18.58
Calculated EPS (Adj) (Unit Curr.)	18.45	11.87	9.18	7.62	18.48	18.58
Calculated EPS (Ann.) (Unit Curr.)	73.81	47.47	36.71	30.50	73.93	74.32
Calculated EPS (Adj) (Ann.) (Unit Curr.)	73.81	47.47	36.71	30.50	73.93	74.32
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	41.55	41.55	41.55	41.55	41.55	41.55
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	29.91	26.56	22.77	21.26	28.33	30.91
PBDTM(%)	27.30	22.28	18.32	17.23	24.95	27.00
PATM(%)	14.61	10.46	7.97	6.96	13.66	14.35

Column	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Gross Sales	524.63	471.52	478.15	454.89	562.18	537.84
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	524.63	471.52	478.15	454.89	562.18	537.84
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.13	2.46	1.00	1.52	4.54	-0.26
Total Income	526.77	473.98	479.15	456.42	566.72	537.58
Total Expenditure	369.24	348.98	370.43	359.87	407.53	371.32
PBIDT	157.52	125.01	108.72	96.55	159.18	166.27
Interest	13.69	20.19	21.27	18.33	18.99	21.03
PBDT	143.84	104.82	87.45	78.21	140.20	145.23
Depreciation	30.38	30.88	31.51	30.80	30.13	30.84
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	19.94	13.58	10.34	8.85	20.08	20.69
Deferred Tax	16.24	11.27	7.61	7.05	13.25	16.51
Reported Profit After Tax	77.28	49.08	38.00	31.51	76.73	77.20
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	77.28	49.08	38.00	31.51	76.73	77.20

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	77.28	49.08	38.00	31.51	76.73	77.20

EPS (Unit Curr.)	18.60	11.81	9.14	7.58	18.47	18.58
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	25.00
Equity	41.55	41.55	41.55	41.55	41.55	41.55

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	30.02	26.51	22.74	21.22	28.31	30.91
PBDTM(%)	27.42	22.23	18.29	17.19	24.94	27.00
PATM(%)	14.73	10.41	7.95	6.93	13.65	14.35

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	151.55	252.47	252.47	252.47	252.11	70.76
Reserves Total	1027.62	684.42	431.66	331.00	240.66	446.57
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	1179.17	936.89	684.13	583.47	492.77	517.33
Secured Loans	766.14	778.44	538.31	526.21	367.71	74.28
Unsecured Loans	2.62	3.76	3.76	0.00	22.00	0.00
Total Debt	768.76	782.20	542.07	526.21	389.71	74.28
Total Liabilities	1947.93	1719.09	1226.20	1109.68	882.48	591.61
APPLICATION OF FUNDS :
Gross Block	2319.70	1474.54	1423.69	688.31	499.11	497.56
Less : Accumulated Depreciation	515.65	406.71	321.38	248.13	204.39	150.35
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1804.05	1067.83	1102.31	440.18	294.72	347.21
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	158.10	589.25	125.84	691.16	468.25	78.80
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	20.62	0.05	0.05	0.00	0.00	71.42
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	211.83	154.14	53.96	48.40	40.65	29.60
Sundry Debtors	166.32	256.32	118.84	76.45	77.36	76.86
Cash and Bank	15.06	25.04	0.68	0.10	129.21	5.08
Loans and Advances	26.24	11.40	7.81	7.13	7.08	3.73
Total Current Assets	419.45	446.89	181.29	132.08	254.32	115.28
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	314.62	300.33	189.92	156.72	152.75	75.47
Provisions	0.25	9.60	0.20	0.18	0.05	3.51
Total Current Liabilities	314.87	309.93	190.11	156.90	152.80	78.97
Net Current Assets	104.58	136.96	-8.82	-24.81	101.51	36.31
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.95	22.62	0.00
Deferred Tax Liability	166.73	91.75	30.81	0.00	22.34	0.00
Net Deferred Tax	-166.73	-91.75	-30.81	0.95	0.28	0.00
Total Assets	1920.62	1702.34	1188.57	1107.47	864.75	533.75
Contingent Liabilities	43.75	79.14	12.95	8.15	0.00	67.86

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	25.04	0.68	0.10	129.21	0.07
Net Cash from Operating Activities	626.16	283.82	229.22	164.68	261.35
Net Cash Used In Investing Activities	-437.22	-454.68	-196.73	-363.21	-217.30
Net Cash Used In Financing Activities	-199.79	195.22	-31.90	69.41	85.09
Net Inc./Dec In Cash And Cash Equivalents	-10.85	24.36	0.58	-129.12	129.14
Cash And Cash Equivalents At End Of The Year	14.19	25.04	0.68	0.10	129.21

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

71.49%

FII Shareholding

1.36%

DII Shareholding

0.05%

Public Shareholding

27.10%

**Promoter pledged shareholding 71.49%

About Epigral Ltd

Epigral Ltd is in the Chemicals sector, having a market capitalization of Rs. 5498.12 crores. It has reported a sales of Rs. 524.63 crores and a net profit of Rs. 76.67 crores for the quarter ended December 2018. The company management includes Maulik Jayantibhai Patel, Maulik Jayantibhai Patel,Kaushal Ashishbhai Soparkar,Karana Rameshbhai Patel,Ankit Natwarlal Patel,Darshan Anandbhai Patel,Manubhai Khodidas Patel,NIRALI BHAVIN PARIKH,Sanjay K Asher,Kanubhai S Patel,Raju Swamy (Epigral Ltd) among others.

Chairman

Maulik Jayantibhai Patel

Registered office

CH/1 CH/2 GIDC Indl Estate,Dahej Tal Vagra,Bharuch,Gujarat,392130

FAX :91-79-29709605

Background

Incorporation Year2007

Face Value₹10

Market Lot1

How to buy Epigral shares on nse?

To buy Epigral shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Epigral share price today?

The Epigral shares price on nse is Rs.1323.25 today.

What is the market cap of Epigral shares on BSE ?

The company has a market capitalization of Rs.5498.12Cr

What is the PE & PB ratio of Epigral shares ?

PE is 28.08 and PB is 4.38

What is the 52 Week High and Low of Epigral shares?

Epigral stock price high: Rs.1438.75 Epigral stock price low: Rs.870